Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001250853-14-000025

Director sold 200,000 shares at $6.90 ($1,380,000)

  • Director acquired 200,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Nisi Rudolph Director 2014-01-15 Option exercise +100,000 $1.18 $118,000 103,500 D
Nisi Rudolph Director 2014-01-15 Option exercise +100,000 $0.85 $85,000 203,500 D
Nisi Rudolph Director 2014-01-17 Sale −200,000 $6.90 $1,380,000 3,500 D
Derivatives
Nisi Rudolph Director 2014-01-15 Option exercise · Stock Option (right to buy) −100,000 0 D
Nisi Rudolph Director 2014-01-15 Option exercise · Stock Option (right to buy) −100,000 0 D
Open-market sales · 200,000 sh · avg $6.90 · $1,380,000
Loading xslF345X03/primary_doc.xml…